Acute Pericarditis Work-Up and Initial Management
For suspected acute pericarditis, obtain physical examination, ECG, chest x-ray, echocardiogram, CRP, and troponin, then immediately initiate combination therapy with high-dose NSAIDs (aspirin 750-1000 mg every 8 hours OR ibuprofen 600 mg every 8 hours) plus colchicine (0.5 mg once daily if <70 kg or 0.5 mg twice daily if ≥70 kg) with gastroprotection. 1
Diagnostic Criteria
Diagnose acute pericarditis when at least 2 of the following 4 criteria are present 1:
- Chest pain: Sharp, pleuritic, worse when supine, relieved by sitting forward (present in ~90% of cases) 2
- Pericardial friction rub: Highly specific but transient (present in <30% of cases) 1, 3
- ECG changes: New widespread ST-segment elevation with PR depression (present in 25-50% of cases) 2
- Pericardial effusion: New or worsening effusion on echocardiography (present in ~60%, usually small) 2
Initial Diagnostic Work-Up
Mandatory baseline tests 1:
- Physical examination (listen for friction rub, assess for tamponade signs)
- 12-lead ECG (look for diffuse ST elevation, PR depression)
- Chest x-ray (assess cardiac silhouette, rule out pulmonary pathology)
- Transthoracic echocardiogram (quantify effusion size, assess for tamponade)
- C-reactive protein (CRP) - essential for guiding treatment duration and monitoring response 1
- Troponin (elevated in myopericarditis, indicates higher risk)
Risk Stratification
High-risk features requiring hospital admission and etiologic search 1:
- Fever >38°C (>100.4°F)
- Subacute onset (symptoms developing over days-weeks)
- Large pericardial effusion (>20 mm echo-free space)
- Cardiac tamponade
- Failure to respond to NSAIDs after 7 days
- Myopericarditis (elevated troponin with myocardial involvement)
- Immunosuppression
- Trauma
- Oral anticoagulation therapy
Low-risk patients without these features can be managed as outpatients with close follow-up 1.
First-Line Treatment
Combination therapy is mandatory 1:
NSAIDs (Class I, Level A recommendation) 1
Choose ONE of:
- Aspirin: 750-1000 mg every 8 hours for 1-2 weeks
- Ibuprofen: 600 mg every 8 hours for 1-2 weeks
Always provide gastroprotection (proton pump inhibitor) 1
PLUS Colchicine (Class I, Level A recommendation) 1
- <70 kg: 0.5 mg once daily
- ≥70 kg: 0.5 mg twice daily
- Duration: 3 months for first episode 1
Critical point: Colchicine reduces recurrence rates by approximately 50% (from 37.5% to 16.7%) 2. This is a Class I recommendation with Level A evidence, meaning it should be used in virtually all patients without contraindications 1.
Treatment Duration and Tapering
- Continue NSAIDs until symptoms resolve AND CRP normalizes (typically 1-2 weeks) 1
- Taper NSAIDs gradually: Decrease aspirin by 250-500 mg every 1-2 weeks; decrease ibuprofen by 200-400 mg every 1-2 weeks 1
- Monitor CRP to guide treatment length and assess response 1
- Continue colchicine for full 3 months (tapering not mandatory) 1
When NOT to Use Corticosteroids
Corticosteroids are NOT recommended as first-line therapy (Class III recommendation) 1. They increase recurrence risk and promote drug dependence 1. Reserve corticosteroids only for:
- Contraindication/failure of both NSAIDs AND colchicine
- Infectious cause has been excluded
- Specific indication (autoimmune disease, pregnancy >20 weeks) 1
If corticosteroids are necessary, use low-dose prednisone 0.2-0.5 mg/kg/day (NOT high-dose 1.0 mg/kg/day) 1.
Activity Restriction
- Non-athletes: Restrict exercise until symptoms resolve and CRP, ECG, and echocardiogram normalize 1
- Athletes: Minimum 3-month restriction from competitive sports after symptom onset, even after normalization of tests 1
This restriction prevents complications during the inflammatory phase and reduces recurrence risk.
Etiologic Investigation
In developed countries, 80-90% of cases are idiopathic/presumed viral 4. Extensive etiologic workup has low diagnostic yield and should be reserved for:
- High-risk features present
- Failure to respond to empiric NSAID therapy
- Specific clinical suspicion (tuberculosis in endemic areas, malignancy, autoimmune disease) 1, 5
Common Pitfalls to Avoid
- Omitting colchicine: This is the single most important error—colchicine is NOT optional and dramatically reduces recurrence 1, 2
- Using corticosteroids first-line: Increases recurrence rates to 50% after first recurrence 1
- Inadequate treatment duration: Stopping NSAIDs before CRP normalizes leads to recurrence 1
- Not tapering NSAIDs: Abrupt discontinuation increases recurrence risk 1
- Missing high-risk features: These patients require admission and cannot be managed outpatient 1
Prognosis
Most patients (70-85%) with idiopathic/viral pericarditis have excellent prognosis 2. However, 15-30% develop recurrence without colchicine therapy 1. Cardiac tamponade occurs in <3% and constrictive pericarditis in <1% of idiopathic cases 2, 1.